ASND Ascendis Pharma A/S - American Depositary Shares
$248.81
Price · Aug 18, 2026
52W Range
$186–$282
65% of range
Analyst Rating
BUY
26 analysts
Price Target
$311
+25% upside
P/E (TTM)
—
ROE
—
Net Profit Margin
—
About Ascendis Pharma A/S - American Depositary Shares Company overview from Wikipedia
ASND Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$248.81
Market Cap
—
P/E (TTM)
—
EPS (TTM)
—
Revenue (TTM)
—
Div Yield
—
ROE
—
Debt/Equity
—
52W Range
$186 – $282
ASND Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Configure
10-Year Performance Revenue, net income, margins and EPS trends
Revenue & Net Income
—
EPS
—
Free Cash Flow
—
Margins
—
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Metric
5Y trend
ASND
Peer Median
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Metric
5Y trend
ASND
Peer Median
Financial Health Debt, liquidity, solvency — balance sheet strength
Metric
5Y trend
ASND
Peer Median
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Metric
5Y trend
ASND
Peer Median
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Metric
5Y trend
ASND
Peer Median
ASND Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
BUY
26 analysts
- Strong Buy 12 46.2%
- Buy 13 50.0%
- Hold 1 3.8%
- Sell 0 0.0%
- Strong Sell 0 0.0%
12-Month Price Target
18 analysts · 2026-08-19
Median
$306.74
← Below all targets
$248.81
Low
$261.64
High
$361.54
Median target
$306.74
+23.3%
Mean target
$310.59
+24.8%
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
-0.34%
| Period | EPS Actual | EPS Est | Surprise |
|---|---|---|---|
| March 31, 2026 | $-0.77 | $0.21 | -0.98% |
| Dec. 31, 2025 | $-0.55 | $-0.05 | -0.50% |
| Sept. 30, 2025 | $-1.00 | $-0.22 | -0.78% |
| June 30, 2025 | $-0.64 | $-1.27 | 0.63% |
| March 31, 2025 | $-1.58 | $-1.52 | -0.06% |
Peer comparison (GICS sub-industry) Key metrics vs sector peers
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| ASND | — | — | — | — | — | — |
| EVAX | — | — | — | — | — | — |
Latest News Recent headlines mentioning this company
My Metrics Your personal watchlist — selected rows from Full Fundamentals
📊
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Institutional owners (13F) 28 filers · $342.9M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 2 | 253 | 4 | 1 | — |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair. Change vs prior quarter not shown: filer coverage differs too much between these two quarters for a reliable comparison.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| STATE STREET CORP | $137,085,812 | 513,969 | 39.98% | Shares |
| Frazier Life Sciences Management, L.P. | $60,053,342 | 225,155 | 17.51% | Shares |
| Camber Capital Management LP | $43,150,000 | 250,000 | 12.58% | Shares |
| ODDO BHF ASSET MANAGEMENT SAS | $34,315,395 | 128,657 | 10.01% | Shares |
| NEUBERGER BERMAN GROUP LLC | $31,982,662 | 119,911 | 9.33% | Shares |
| Quadrature Capital Ltd | $10,894,178 | 40,845 | 3.18% | Shares |
| TWO SIGMA ADVISERS, LP | $10,107,576 | 47,400 | 2.95% | Shares |
| Matisse Capital | $5,964,592 | 26,077 | 1.74% | Shares |
| Nuveen Asset Management, LLC | $1,986,578 | 14,430 | 0.58% | Shares |
| CIBC Private Wealth Group LLC | $1,665,630 | 8,378 | 0.49% | Shares |
| Advisors Asset Management, Inc. | $1,134,538 | 8,241 | 0.33% | Shares |
| Skopos Labs, Inc. | $931,389 | 4,072 | 0.27% | Shares |
| Asset Management One Co., Ltd. | $870,318 | 3,805 | 0.25% | Shares |
| FERGUSON WELLMAN CAPITAL MANAGEMENT, INC | $693,472 | 2,600 | 0.20% | Shares |
| MidWestOne Financial Group, Inc. | $654,007 | 3,067 | 0.19% | Shares |
| DEARBORN PARTNERS LLC | $346,736 | 1,300 | 0.10% | Shares |
| Springhill Fund Asset Management (HK) Co Ltd | $338,684 | 2,173 | 0.10% | Shares |
| CWM, LLC | $308,099 | 1,347 | 0.09% | Shares |
| Shilanski & Associates, Inc. | $259,248 | 1,304 | 0.08% | Shares |
| Lindbrook Capital, LLC | $44,264 | 284 | 0.01% | Shares |
| FTB Advisors, Inc. | $40,561 | 235 | 0.01% | Shares |
| E Fund Management (Hong Kong) Co., Ltd. | $22,404 | 84 | 0.01% | Shares |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $10,293 | 45 | 0.00% | Shares |
| Ninepoint Partners LP | $6,935 | 26 | 0.00% | Shares |
| Handelsbanken Fonder AB | $3,538 | 15,467 | 0.00% | Shares |
| IFP Advisors, Inc | $3,423 | 14 | 0.00% | Shares |
| Binnacle Investments Inc | $596 | 3 | 0.00% | Shares |
| HUNTINGTON NATIONAL BANK | $244 | 1 | 0.00% | Shares |
Company insiders 2 insiders · 1 officers · 1 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Scott Thomas Smith | EVP & Chief Financial Officer | June 2, 2026 P | 4,367 | 2 | 0 | $77,730 |
| Jean Jacques Bienaime | Director | Aug. 14, 2026 P | 2,900 | 7 | 0 | $699,338 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
Activists & 5%+ owners 5 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| OrbiMed Advisors LLC, OrbiMed Capital GP V LLC, OrbiMed Global Healthcare GP LLC, OrbiMed Capital LLC ×16 filings | May 22, 2020 | — | Initial filing | — | SEC |
| Vivo Ventures VII, LLC, Vivo Ventures Fund VII, L.P., Vivo Ventures VII Affiliates Fund, L.P., Vivo Opportunity, LLC, Vivo Opportunity Fund, L.P. ×3 filings | Oct. 23, 2019 | — | Initial filing | — | SEC |
| Sofinnova Venture Partners IX, L.P. (“SVP IX”), Sofinnova Management IX, L.L.C. (“SM IX”), Dr. Michael F. Powell (“Powell”), Dr. James I. Healy (“Healy”), Dr. Anand Mehra (“Mehra”) ×5 filings | Feb. 12, 2019 | — | Initial filing | — | SEC |
| Sofinnova Capital V FCPR (“SC V”), Sofinnova Partners SAS, a French corporation (“SP SAS”), Denis Lucquin (“Lucquin”), Antoine Papiernik (“Papiernik”), Monique Saulnier (“Saulnier”) ×3 filings | Feb. 14, 2018 | — | Initial filing | — | SEC |
| Vivo Ventures VII, LLC FEIN, Vivo Ventures Fund VII, L.P. FEIN, Vivo Ventures VII Affiliates Fund, L.P. FEIN | Feb. 17, 2015 | — | Initial filing | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF ownership Held by 23 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| BBP · ETFis Series Trust I | 1.66% | 4,293 NS | April 30, 2026 | N-PORT |
| IBB · iShares Trust | 1.19% | 454,026 SH | Aug. 8, 2026 | Daily |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 1.07% | 3,350 SH | Aug. 8, 2026 | Daily |
| QQQJ · Invesco Exchange-Traded Fund Trust … | 0.76% | 35,127 SH | Aug. 8, 2026 | Daily |
| IWP · iShares Trust | 0.34% | 271,570 SH | Aug. 8, 2026 | Daily |
| IDHQ · Invesco Exchange-Traded Fund Trust … | 0.25% | 9,607 SH | Aug. 8, 2026 | Daily |
| IYH · iShares Trust | 0.20% | 29,776 SH | Aug. 8, 2026 | Daily |
| SMMD · iShares Trust | 0.17% | 24,824 SH | Aug. 8, 2026 | Daily |
| FTLS · First Trust Exchange-Traded Fund III | 0.16% | 15,586 NS | April 30, 2026 | N-PORT |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0.10% | 3,233 SH | Aug. 8, 2026 | Daily |
| IWR · iShares Trust | 0.09% | 202,715 SH | Aug. 8, 2026 | Daily |
| PDN · Invesco Exchange-Traded Fund Trust … | 0.06% | 890 SH | Aug. 8, 2026 | Daily |
| VONG · VANGUARD SCOTTSDALE FUNDS | 0.04% | 74,541 SH | Aug. 8, 2026 | Daily |
| IWF · iShares Trust | 0.04% | 177,330 SH | Aug. 8, 2026 | Daily |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0.02% | 8,179 SH | Aug. 8, 2026 | Daily |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.02% | 4,200 SH | Aug. 8, 2026 | Daily |
| IWB · iShares Trust | 0.02% | 34,486 SH | Aug. 8, 2026 | Daily |
| IWV · iShares Trust | 0.02% | 13,537 SH | Aug. 8, 2026 | Daily |
| FDG · AMERICAN CENTURY ETF TRUST | 0.02% | 308 NS | May 31, 2026 | N-PORT |
| OMFL · Invesco Exchange-Traded Self-Indexe… | 0.01% | 2,134 SH | Aug. 8, 2026 | Daily |
| IWS · iShares Trust | 0.01% | 4,144 SH | Aug. 8, 2026 | Daily |
| IWD · iShares Trust | 0.00% | 6,101 SH | Aug. 8, 2026 | Daily |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0.00% | 1,675 SH | Aug. 8, 2026 | Daily |